You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

trametinib

Showing 51 - 75 of 133
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

KRAS Gene Mutation, Metastatic Non-Squamous Non-Small Cell Lung Carcinoma, Recurrent Non-Squamous Non-Small Cell Lung Carcinoma

Active, not recruiting
  • KRAS Gene Mutation
  • +3 more
  • Pembrolizumab
  • Trametinib
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Nov 1, 2021

Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)

Recruiting
  • Cancer
  • Trametinib
  • +14 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 4, 2022

Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

Recruiting
  • Advanced Cancer
  • Solid Tumor
  • Helsinki, Uusimaa, Finland
  • +2 more
Jun 8, 2022

Melanoma Trial in Italy (dabrafenib, Trametinib)

Recruiting
  • Melanoma
  • Meldola, Forlì-Cesena, Italy
  • +15 more
Mar 18, 2022

Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Carcinoma Trial in United States (Laboratory

Active, not recruiting
  • Metastatic Colon Carcinoma
  • +24 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Corona, California
  • +7 more
Oct 26, 2022

Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Trametinib
  • +2 more
  • Miami, Florida
    University of Miami
Jun 27, 2022

Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation Trial in Villejuif (Trametinib,

Active, not recruiting
  • Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
  • Trametinib
  • +3 more
  • Villejuif, Val De Marne, France
    Gustave Roussy
Sep 27, 2021

Hepatocellular Cancer, Liver Cancer Trial in Tampa (Trametinib, Sorafenib)

Completed
  • Hepatocellular Cancer
  • Liver Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 9, 2021

Malignant Melanoma Trial in Herlev, Aarhus, Odense (Pembrolizumab Injection [Keytruda], Ipilimumab Injection [Yervoy], Nivolumab

Recruiting
  • Malignant Melanoma
  • Pembrolizumab Injection [Keytruda]
  • +6 more
  • Herlev, Hovedstaden, Denmark
  • +2 more
Sep 16, 2022

Melanoma, Brain Metastases Trial in Canada (Dabrafenib, Trametinib)

Terminated
Has Results
  • Melanoma
  • Brain Metastases
  • Halifax, Nova Scotia, Canada
  • +5 more
Aug 18, 2021

Cancer Trial in Worldwide (Trametinib, Dabrafenib)

Completed
Has Results
  • Cancer
  • Phoenix, Arizona
  • +15 more
Jun 21, 2021

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Melanoma Trial in Boston (drug, biological, other)

Terminated
  • BRAF V600E Mutation Present
  • +7 more
  • Boston, Massachusetts
  • +1 more
Mar 9, 2022

Soft Tissue Sarcoma Trial in France (drug, combination product, other)

Recruiting
  • Soft Tissue Sarcoma
  • Bordeaux, France
  • +17 more
Oct 4, 2022

Melanoma Trial in Jette (Dabrafenib, Trametinib, Hydroxychloroquine)

Recruiting
  • Melanoma
  • Jette, Brabant, Belgium
    UZ Brussel
Apr 27, 2021

Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)

Recruiting
  • Diffuse Astrocytoma
  • +22 more
  • Phoenix, Arizona
  • +26 more
Jan 27, 2023

Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

Recruiting
  • Thyroid Cancer
  • +6 more
  • Trametinib
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 19, 2023

EGFR-mutant NSCLC Trial in Worldwide (EGF816, trametinib, ribociclib)

Active, not recruiting
  • EGFR-mutant Non-small Cell Lung Cancer
  • Toronto, Ontario, Canada
  • +10 more
Dec 5, 2022

Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma Trial in United States (trametinib, laboratory biomarker analysis,

Completed
Has Results
  • Recurrent Melanoma
  • +3 more
  • trametinib
  • +2 more
  • Washington, District of Columbia
  • +3 more
May 4, 2021

Non Small Cell Lung Cancer Trial in Shanghai (Trametinib, Anlotinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Jan 16, 2022

Prostate Cancer Trial in Los Angeles (degarelix, enzalutamide, trametinib)

Active, not recruiting
  • Prostate Cancer
  • Los Angeles, California
    University of California, Los Angeles
Aug 25, 2022

Multiple Myeloma Trial in Boston, Detroit (Dabrafenib, Trametinib)

Unknown status
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Feb 22, 2021

Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Australia, United States (AMG 232, Trametinib, Dabrafenib)

Completed
  • Advanced Malignancy
  • +6 more
  • AMG 232
  • +2 more
  • Los Angeles, California
  • +6 more
Mar 24, 2021

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +5 more
  • Boston, Massachusetts
  • +4 more
May 25, 2022

Melanoma Trial in Boston, Harrison, New York (Dabrafenib, Trametinib, Phenformin)

Active, not recruiting
  • Melanoma
  • Boston, Massachusetts
  • +2 more
Jun 14, 2022

Targeted Therapies in BRAF Positive Metastatic Melanoma in US

Active, not recruiting
  • Melanoma
  • New York, New York
    Pfizer Investigational Site
Feb 18, 2022